Literature DB >> 33755782

Associations between SNP83 of phosphodiesterase 4D gene and carotid atherosclerosis in a southern Chinese Han population: a case-control study.

Liu-Yu Liu1, Dong-Can Mo1, Jian-Li Li1, Yi-Ying Jiang1, Guo-Qiu Zhou1, Dong-Dong Jiang1, Li-Jie Chen1, Xiao-Ju Wu1, Jiao-Xing Li2, Man Luo3.   

Abstract

Atherosclerosis was an important pathophysiological basis of atherothrombotic stroke, and phosphodiesterase 4D (PDE4D) polymorphism (SNP83/rs966221) was reported to be associated with the susceptibility to atherothrombotic stroke. Aim of the present study was to explore the potential association between SNP83 and carotid atherosclerosis (CAS). 204 southern Chinese Han participants were divided into two groups according to the carotid intima-media thickness (IMT) of the carotid artery: CAS group (carotid IMT ≥ 1.0 mm) and non-CAS group (carotid IMT < 1.0 mm). Carotid IMT was measured by color Doppler ultrasound. The PDE4D SNP83 polymorphism was determined by SNaPshot technique. Our study found that SNP83 was associated significantly with CAS susceptibility under the dominant, overdominant and codominant models. After adjusting for age, gender, low-density lipoprotein cholesterol, Hemoglobin A1c, cigarette smoking, hypertension history, and diabetes mellitus history, the association still remained significant (dominant model: crude OR = 2.373, 95% CI: 1.268-4.442, P = 0.007; adjusted OR = 3.129, 95% CI: 1.104-8.866, P = 0.032; overdominant model: crude OR = 1.968, 95% CI: 1.043-3.714, P = 0.037; adjusted OR = 2.854, 95% CI: 1.005-8.108, P = 0.049; codominant: crude OR = 2.102, 95% CI: 1.110-3.979, P = 0.023; adjusted OR = 2.984, 95% CI: 1.047-8.502, P = 0.041). Carotid IMT of carriers with CT + CC genotypes was higher than carriers with TT genotype (P = 0.016). Our results indicated that the SNP83/rs966221 located on PDE4D gene was significantly associated between CAS susceptibility and carotid IMT independently of conventional risk factors in a southern Chinese Han population.

Entities:  

Year:  2021        PMID: 33755782     DOI: 10.1007/s00335-021-09857-5

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  29 in total

1.  Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK).

Authors:  G Baillie; S J MacKenzie; M D Houslay
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

2.  Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.

Authors:  S Fukumoto; H Koyama; M Hosoi; K Yamakawa; S Tanaka; H Morii; Y Nishizawa
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

3.  Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.

Authors:  S-L Catherine Jin; Marco Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.

Authors:  S Ebrahim; O Papacosta; P Whincup; G Wannamethee; M Walker; A N Nicolaides; S Dhanjil; M Griffin; G Belcaro; A Rumley; G D Lowe
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

5.  8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo.

Authors:  C Indolfi; E Di Lorenzo; A Rapacciuolo; A M Stingone; E Stabile; A Leccia; D Torella; R Caputo; F Ciardiello; G Tortora; M Chiariello
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

6.  Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men.

Authors:  Ryuichi Kawamoto; Hitomi Tomita; Ai Inoue; Nobuyuki Ohtsuka; Atsushi Kamitani
Journal:  J Atheroscler Thromb       Date:  2007-02       Impact factor: 4.928

7.  Localization of a susceptibility gene for common forms of stroke to 5q12.

Authors:  Solveig Gretarsdottir; Sigurlaug Sveinbjörnsdottir; Hjörtur H Jonsson; Finnbogi Jakobsson; Elisabet Einarsdottir; Uggi Agnarsson; Dana Shkolny; Gisli Einarsson; Herdis M Gudjonsdottir; Einar M Valdimarsson; Olafur B Einarsson; Gudmundur Thorgeirsson; Radinka Hadzic; Sif Jonsdottir; Sigridur Th Reynisdottir; Sigrun M Bjarnadottir; Thorunn Gudmundsdottir; Gudrun J Gudlaugsdottir; Ramanjit Gill; Klaus Lindpaintner; Jesus Sainz; Helgi H Hannesson; Gunnar Th Sigurdsson; Michael L Frigge; Augustine Kong; Vilmundur Gudnason; Kari Stefansson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2002-02-06       Impact factor: 11.025

8.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.

Authors:  Solveig Gretarsdottir; Gudmar Thorleifsson; Sigridur Th Reynisdottir; Andrei Manolescu; Sif Jonsdottir; Thorbjörg Jonsdottir; Thorunn Gudmundsdottir; Sigrun M Bjarnadottir; Olafur B Einarsson; Herdis M Gudjonsdottir; Malcolm Hawkins; Gudmundur Gudmundsson; Hrefna Gudmundsdottir; Hjalti Andrason; Asta S Gudmundsdottir; Matthildur Sigurdardottir; Thomas T Chou; Joseph Nahmias; Shyamali Goss; Sigurlaug Sveinbjörnsdottir; Einar M Valdimarsson; Finnbogi Jakobsson; Uggi Agnarsson; Vilmundur Gudnason; Gudmundur Thorgeirsson; Jurgen Fingerle; Mark Gurney; Daniel Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Jeffrey R Gulcher
Journal:  Nat Genet       Date:  2003-09-21       Impact factor: 38.330

Review 9.  PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.

Authors:  Katharine H Banner; Michael A Trevethick
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.